We are monitoring the impact of COVID-19 on Europe PEGylated Proteins Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 3225
Share on
Share on

Europe PEGylated Proteins Market Research Report - Segmented By Protein Type, By Application, By Consumables, End-User & By Country(UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2019-2024)

Pulished: February, 2020
ID: 3225
Pages: 135

Europe PEGylated Proteins Market Size & Growth (2019 - 2024)

As per the research report, the size of the Europe PEGylated Proteins Market is valued at USD 208.56 million in 2019 and estimated to be growing at a CAGR of 10.20%, to reach USD 338.95 million by 2024. The market is showing great potential in the forecast period, i.e. till 2019-2024.

PEGylation is a process of attachment of covalent or non-covalent bond of PolyEthylene Glucol (PEG) polymer chains to molecules and macrostructures, like protein in case of PEGylation of proteins. PEGylated Protein has become very important because the PEGylation of proteins helps to protect protein against enzymatic dehydration and it also increases the half-life of drugs.

Increasing R&D investments in pharmaceuticals and healthcare sectors in this region because of high awareness of people regarding health-related issues, high risk of diseases, increase in adoption of protein-based drugs over non-protein based drugs and increased half-life of drugs due to PEGylation are the major driving factors of this market. On the other hand, the unpredictable accumulation of high molecular weight compounds in the liver might lead to inclusion bodies with no known consequences. Furthermore, the chain length of these compounds can change which might lead to unexpected clearance times in vivo. These concerning matters are challenging this market.

This research report segmented and sub-segmented into the following categories:

  • By Protein Type: Interferons, Erythropoietin, MAbs
  • By Application: Chronic Kidney Diseases, Cancer Treatment
  • By Consumables: Reagents, PEGylation Kits
  • By End-User: Pharmaceutical & Biotechnology Companies, CROs, Academic Research Institutes
  • By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe

In Europe, Germany leads the PEGylated Proteins Market, followed by France and U.K. The market in this region is projected to grow strongly during the forecast period due to various factors such as growing awareness about health and pharmacy, financial strength to procure expensive medicines and favorable reimbursement policies.

Key players operating in the Europe PEGylated Proteins Market profiled in this report are Laysan Bio, Ltd., Iris Biotech GmbH, Biomatrik Inc., Quanta BioDesign Ltd., Cealares GmbH, Creative PEGworks, Jenkem Technology USA Inc., NOF Corporation, Thermo Fisher Scientific Inc., and Merck Millipore.

1.Introduction           

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods   

                1.4 General Study Assumptions                

2. Research Methodology                    

                2.1 Introduction        

                2.2 Research Phases                      

         2.2.1 Secondary Research           

         2.2.2 Primary Research 

         2.2.3 Econometric Modelling      

         2.2.4 Expert Validation  

                2.3 Analysis Design  

                2.4 Study Timeline   

3. Overview                

                3.1 Executive Summary                

                3.2 Key Inferences  

                3.3 Epidemology       

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)             

                4.1 Market Drivers   

                4.2 Market Restraints                    

                4.3 Key Challenges  

                4.4 Current Opportunities in the Market       

5. Market Segmentation

                5.1 Protein Type       

         5.1.1 Introduction           

         5.1.2 Interferons             

         5.1.3 Erythropoietin       

         5.1.4 mAbs         

         5.1.5  Y-o-Y Growth Analysis, By Protein Type    

         5.1.6  Market Attractiveness Analysis, By Protein Type  

         5.1.7  Market Share Analysis, By Protein Type    

                5.2 Consumables      

         5.2.1 Introduction           

         5.2.2 Reagents 

         5.2.3 PEGylation Kits      

         5.2.4 Y-o-Y Growth Analysis, By Consumables    

         5.2.5 Market Attractiveness Analysis, By Consumables  

         5.2.6 Market Share Analysis, By Consumables    

                5.3 Application                 

         5.3.1 Introduction           

         5.3.2 Chronic Kidney Diseases   

         5.3.3 Cancer Treatment

         5.3.4 Y-o-Y Growth Analysis, By Application         

         5.3.5  Market Attractiveness Analysis, By Application      

         5.3.6  Market Share Analysis, By Application       

                5.4 End-Users                   

         5.4.1 Introduction           

                                5.4.2 Pharmaceuticals & Biotechnology Companies         

         5.4.3 CROs          

         5.4.4 Academic Research Institutes         

         5.4.5 Y-o-Y Growth Analysis, By End-Users          

         5.4.6  Market Attractiveness Analysis, By End-Users       

         5.4.7  Market Share Analysis, By End-Users         

6. Geographical Analysis

                6.1 Introduction        

         6.1.1 Regional Trends    

         6.1.2 Impact Analysis     

         6.1.3 Y-o-Y Growth Analysis        

  6.1.3.1 By Geographical Area

  6.1.3.2 By Protein Type

  6.1.3.3 By Consumables

  6.1.3.4 By Application

  6.1.3.5 By End-Users

         6.1.4  Market Attractiveness Analysis     

  6.1.4.1 By Geographical Area

  6.1.4.2 By Protein Type

  6.1.4.3 By Consumables

  6.1.4.4 By Application

  6.1.4.5 By End-Users

         6.1.5  Market Share Analysis      

  6.1.5.1 By Geographical Area

  6.1.5.2 By Protein Type

  6.1.5.3 By Consumables

  6.1.5.4 By Application

  6.1.5.5 By End-Users

                6.2 U.K                 

                6.3 Spain      

                6.4 Germany                     

                6.5 Italy        

                6.6 France   

7.Strategic Analysis                 

                7.1 PESTLE analysis  

         7.1.1 Political     

         7.1.2 Economic 

         7.1.3 Social         

         7.1.4 Technological         

         7.1.5 Legal          

         7.1.6 Environmental       

                7.2 Porter’s Five analysis       

         7.2.1 Bargaining Power of Suppliers        

         7.2.2 Bargaining Power of Consumers    

         7.2.3 Threat of New Entrants     

         7.2.4 Threat of Substitute Products and Services              

         7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                  

                8.1 Laysan Bio Ltd.   

         8.1.1 Overview 

         8.1.2 Product Analysis   

         8.1.3 Financial analysis  

         8.1.4 Recent Developments       

         8.1.5 SWOT analysis       

         8.1.6 Analyst View          

                8.2 Iris Biotech GmbH                    

                8.3 Biomatrik Inc.     

                8.4 Quanta BioDesign Ltd.    

                8.5 Cealares GmbH  

                8.6 Creative PEGworks                 

                8.7 Jenkem Technology USA Inc.       

                8.8 NOF Corporation                      

                8.9 Thermo Fisher Scientific Inc.        

                8.10 Merck Millipore                      

9.Competitive Landscape                     

                9.1 Market share analysis     

                9.2 Merger and Acquisition Analysis

                9.3 Agreements, collaborations and Joint Ventures  

                9.4 New Product Launches  

10.Market Outlook and Investment Opportunities                   

Appendix                    

                a) List of Tables                

                b) List of Figures       

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe PEGylated Proteins Market By Protein Type, From 2019-2024 ( USD Million )
  2. Europe Interferons Market By Region, From 2019-2024 ( USD Million )
  3. Europe Erythropoietin Market By Region, From 2019-2024 ( USD Million )
  4. Europe mAbs Market By Region, From 2019-2024 ( USD Million )
  5. Europe PEGylated Proteins Market By End-User, From 2019-2024 ( USD Million )
  6. Europe Pharmaceuticals & Biotechnology Companies Market By Region, From 2019-2024 ( USD Million )
  7. Europe CROs Market By Region, From 2019-2024 ( USD Million )
  8. Europe Academic Research Institutes Market By Region, From 2019-2024 ( USD Million )
  9. Europe PEGylated Proteins Market By Application, From 2019-2024 ( USD Million )
  10. Europe Chronic Kidney Disease Market By Region, From 2019-2024 ( USD Million )
  11. Europe Cancer Treatment Market By Region, From 2019-2024 ( USD Million )
  12. Europe PEGylated Proteins Market By Consumables, From 2019-2024 ( USD Million )
  13. Europe Reagents Market By Region, From 2019-2024 ( USD Million )
  14. Europe PEGylation Kits Market By Region, From 2019-2024 ( USD Million )
  15. U.K. PEGylated Proteins Market By Protein Type, From 2019-2024 ( USD Million )
  16. U.K. PEGylated Proteins Market By End-User, From 2019-2024 ( USD Million )
  17. U.K. PEGylated Proteins Market By Application, From 2019-2024 ( USD Million )
  18. U.K. PEGylated Proteins Market By Consumables, From 2019-2024 ( USD Million )
  19. Germany PEGylated Proteins Market By Protein Type, From 2019-2024 ( USD Million )
  20. Germany PEGylated Proteins Market By End-User, From 2019-2024 ( USD Million )
  21. Germany PEGylated Proteins Market By Application, From 2019-2024 ( USD Million )
  22. Germany PEGylated Proteins Market By Consumables, From 2019-2024 ( USD Million )
  23. France PEGylated Proteins Market By Protein Type, From 2019-2024 ( USD Million )
  24. France PEGylated Proteins Market By End-User, From 2019-2024 ( USD Million )
  25. France PEGylated Proteins Market By Application, From 2019-2024 ( USD Million )
  26. France PEGylated Proteins Market By Consumables, From 2019-2024 ( USD Million )
  27. Italy PEGylated Proteins Market By Protein Type, From 2019-2024 ( USD Million )
  28. Italy PEGylated Proteins Market By End-User, From 2019-2024 ( USD Million )
  29. Italy PEGylated Proteins Market By Application, From 2019-2024 ( USD Million )
  30. Italy PEGylated Proteins Market By Consumables, From 2019-2024 ( USD Million )
  31. Spain PEGylated Proteins Market By Protein Type, From 2019-2024 ( USD Million )
  32. Spain PEGylated Proteins Market By End-User, From 2019-2024 ( USD Million )
  33. Spain PEGylated Proteins Market By Application, From 2019-2024 ( USD Million )
  34. Spain PEGylated Proteins Market By Consumables, From 2019-2024 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample